Status:
COMPLETED
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Lead Sponsor:
Kansai Hepatobiliary Oncology Group
Conditions:
Intrahepatic Cholangiocarcinoma
Eligibility:
All Genders
Brief Summary
To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.
Detailed Description
The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.
Eligibility Criteria
Inclusion
- Cases of major hepatectomy due to intrahepatic cholangiocarcinoma
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01862276
Start Date
March 1 2013
End Date
March 1 2014
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka University, Graduate School of Medicine
Osaka, Osaka, Japan, 565-0871